🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

25 recruiting trials

for Sjögren's Syndrome

Ultra-High Frequency Ultrasonography in Sjögren's Syndrome NCT06338735NA1 site📍 Pisa University of Pisa · Tests: Ultra-High Frequency Ultrasound scan of minor salivary glands Laser Acupuncture on Dry Eye and Sjögren's Syndrome-related Dry Eye Symptoms (LADESJS) NCT06780293Phase 21 site📍 Taipei Taipei Veterans General Hospital, Taiwan · Tests: Laser acupuncture (LA), Numerical Rating Scale (NRS), Schirmer's test, Ocular Surface Disease Index (OSDI), EULAR … Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease NCT07404865Phase 349 sites📍 Chandler📍 Flagstaff📍 Glendale Vor Biopharma · Tests: Telitacicept, Placebo Explanatory Factors and Predictors of Fatigue in Patients With Sjögren's Disease: A 3-month Longitudinal Study NCT07544394n/a1 site📍 Kahramanmaraş Kahramanmaras Sutcu Imam University Autoreactive Anti-Ro/SSA IgE To Determine Primary SjögRen's Syndrome's Disease Activity NCT03003572n/a8 sites📍 Bourgoin📍 Clermont-Ferrand📍 Grenoble Centre Hospitalier Universitaire de Saint Etienne · Tests: Blood samples TREATMENT OF VAGINAL DRYNESS IN SJÖGREN'S DISEASE WITH CO2-LASER VERSUS TOPICAL PROMESTRIENE NCT07153276Phase 41 site📍 São Paulo University of Sao Paulo General Hospital · Tests: Fractional CO2 laser (vaginal), Promestriene Vaginal AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases. NCT06991114Phase 252 sites📍 Tuscaloosa📍 Phoenix📍 Tucson Artiva Biotherapeutics, Inc. · Tests: Allogeneic NK Cells Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden NCT07621809Phase 333 sites📍 Peoria📍 Clearwater📍 Tampa Novartis Pharmaceuticals · Tests: VAY736, Placebo Exosomes Proteomic for Sjogren's Syndrome and Dry Eye Syndrome NCT06771427n/a1 site📍 Taipei Taipei Veterans General Hospital, Taiwan · Tests: acupuncture GB20 or GB20 plus BL2, Chinese herbal tea TBDESJS A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS) NCT06747949Phase 3174 sites📍 Avondale📍 Flagstaff📍 Gilbert Amgen · Tests: Dazodalibep A Trial in Healthy Adult Participants and Adults With Autoimmune Disease to Test How HBM7020 is Tolerated and Absorbed in the Body NCT07649265Phase 11 site📍 Brisbane Otsuka Pharmaceutical Development & Commercialization, Inc. · Tests: HBM7020 Clinical Efficacy of Telitacicept in Sjögren's Disease With Interstitial Lung Disease NCT07843381n/a1 site📍 Beijing Peking University People's Hospital · Tests: Telitacicept 160mg, Conventional treatment Exploring the Novel Value of PSMA PET in Sjögren's Syndrome: Integrated Analysis With Established FAPI PET Imaging NCT07324733NA1 site📍 Beijing Peking Union Medical College Hospital · Tests: ⁶⁸Ga-PSMA PET/CT, ⁶⁸Ga-FAPI PET/CT Diagnostic Suspicion of Primitive Syndrome Sjögren's : Brest Cohort NCT03681964n/a1 site📍 Brest University Hospital, Brest A PHASE II PROSPECTIVE RANDOMIZED DOUBLE-MASKED CONTROLLED STUDY ASSESSING THE SAFETY & EFFICACY OF RHPRG4 (450 µG/ML RECOMBINANT HUMAN PROTEOGLYCAN 4) COMPARED TO VEHICLE FOR THE TREATMENT OF SJÖGREN'S RELATED DRY EYE DISEASE NCT07118241Phase 27 sites📍 Sydney📍 Sydney📍 Brisbane Lubris Bio Pty Ltd · Tests: Recombinant Human Proteoglycan 4, Vehicle Control Intraglandular Treatment With Adipose-derived Mesenchymal Stem Cells in Patients With Xerostomia Due to Sjögren's Disease NCT06805448Phase 1, Phase 21 site📍 Copenhagen Copenhagen University Hospital, Rigshospitalet · Tests: MSC, Saline Water (Control) Fatigue in Sjögren's Syndrome: 3 Therapeutic Strategies NCT06875102NA1 site📍 Saint-Etienne Centre Hospitalier Universitaire de Saint Etienne · Tests: Acupuncture (ACU), Transcutaneous Vagus Nerve Stimulation (tVNS), APA (adapted physical activity ), Acupuncture (sham_A… Dental and Periodontal Status of Patients With Sjögren's Syndrome. NCT04848870n/a1 site📍 Ivry-sur-Seine Assistance Publique - Hôpitaux de Paris · Tests: Salivary samples The Efficacy and Safety of Iguratimod (IGU) in the Treatment of Primary Sjögren's Syndrome NCT04981145Phase 41 site📍 Hangzhou Second Affiliated Hospital, Zhejiang University, School of … · Tests: Iguratimod Tablets, Hydroxychloroquine Sulfate Tablets Evaluating a New Therapy for Dry Eye in Patients With Sjögren's Syndrome NCT07277257Phase 41 site📍 Venice Center For Sight · Tests: TRYPTYR (Acoltremon ophthalmic solution 0.003%) New Clinical End-points in Patients With Primary Sjögren's Syndrome NCT05113004Phase 27 sites📍 Brest📍 Lille📍 Montpellier Assistance Publique - Hôpitaux de Paris · Tests: Hydroxychloroquine 400mg/d, Leflunomide 20mg/d, Mycophenolate mofetil 2000mg/d, Placebo of Hydroxychloroquine 400mg/d, … A Phase 1 Open-label Study to Evaluate Safety in Healthy Participants and Participants With Autoimmune Diseases NCT07284797Phase 11 site📍 Melbourne Xencor, Inc. · Tests: XmAb657 The ASSESS National Multi-center Prospective Cohort NCT03040583n/a1 site📍 Le Kremlin-Bicêtre Assistance Publique - Hôpitaux de Paris · Tests: No intervention A Phase 2a/b Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Sjögren's Disease NCT07737743Phase 222 sites📍 Clearwater📍 Tampa📍 Chicago Novartis Pharmaceuticals · Tests: DDY391, Placebo Analyse of Inflammatory Activity of Sjögren's Syndrome on 68Ga-FAPI PET-CT NCT07062523Phase 1, Phase 21 site📍 Beijing Peking Union Medical College Hospital · Tests: 68Ga-FAPI
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy